Antares Pharma Appoints Joseph Renda as Senior Vice globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
(Separate multiple addresses with a comma)
Your Email Address
Your Message (optional)
Hercules Capital, SVB Provide $60MM Term Loan to SCYNEXIS
May 17, 2021, 08:00 AM
SCYNEXIS secured a $60 million term loan facility with Hercules Capital and Silicon Valley Bank (SVB). The capital strengthens SCYNEXISâ balance sheet ahead of the anticipated commercial launch of Brexafemme, the expected trade name for ibrexafungerp, an oral antifungal product candidate for the treatment of vaginal yeast infections, which is under regulatory review by the U.S. Food and Drug Administration (FDA) with a PDUFA target action date of June 1, 2021. This non-dilutive financing further extends SCYNEXISâ projected cash runway into 2023, based on current operating plans.
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2021 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.